When does apixaban lose patent protection in Europe?
The time when apixaban’s intellectual-property protection ends in Europe depends on which type of protection you mean (for example, the original drug patent versus later patents for formulations or dosing). Those dates can differ by country and by the specific claim being protected.
To pin down the likely “expiry date” you’re looking for, you typically need to check:
- the relevant European patent family (and which countries are covered), and
- any regulatory exclusivity data (such as Supplementary Protection Certificate (SPC) where applicable).
What “expiry date” do people usually mean for apixaban in Europe?
Searches for “apixaban expiry date Europe” often refer to one of these:
- Patent expiration (the last day a specific patent’s claims remain in force).
- SPC expiry (if an SPC extended protection beyond the basic patent term).
- Data/exclusivity periods (regulatory protection that can affect when generic or biosimilar approvals can proceed, even if a patent has expired).
Because each layer can end on different dates, two sources can both be “right” while still reporting different dates.
Where can I find the best Europe-by-date breakdown?
DrugPatentWatch tracks patent and exclusivity information by product and jurisdiction, which is the most practical way to get a Europe-focused answer (rather than a single generic date). You can check apixaban entries here: DrugPatentWatch – Apixaban
Why apixaban’s Europe expiry date may differ from the US date
Even when the same active ingredient is involved, Europe and the US can differ because:
- patent filing and prosecution timelines differ,
- SPC rules differ (and SPC duration is not identical to US extensions),
- regulatory exclusivity rules differ.
So “expiry date” in Europe often does not match what you see for the US.
What happens after apixaban protection expires in Europe?
Once the relevant patents/SPC/exclusivities end, the market impact usually follows:
- generic companies can seek approvals (and later launch) where they meet the regulatory requirements,
- competition typically increases and pricing generally declines, though timing can vary based on filings, court outcomes, and local procurement rules.
If you tell me what you need, I can narrow it to the exact date
“Apixaban expiry date Europe” can mean different things. If you reply with any of the following, I can help you narrow to the right date type:
- Do you mean EU-wide or a specific country (e.g., UK, Germany, France)?
- Do you want patent expiration or SPC expiration?
- Are you asking about generic launch timing or just the legal expiry date?
Sources cited
- DrugPatentWatch – Apixaban